Patents by Inventor Dubravka Markovic

Dubravka Markovic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190269541
    Abstract: An implant configured for ingestion by a patient. After the implant has been swallowed by the patient and is disposed within the target location, e.g. the patient's stomach, an inflation subcomponent causes the implant to expand from a compact delivery state to an expanded, volume-occupying, deployed state. In the deployed state the implant creates a sensation of satiety in the patient stomach and thereby aids in limiting food intake and obesity. After a predetermined time a deflation subcomponent is actuated and the implant reduces in size so as to allow it to pass through the remainder of the patient's digestive track. The device may further incorporate tracking and visualization subcomponents, as well as pharmaceutical delivery subcomponents.
    Type: Application
    Filed: May 16, 2019
    Publication date: September 5, 2019
    Inventors: Mark C. Brister, Nelson Quintana, Kaushik A. Patel, Neil R. Drake, Antonio C. Llevares, Dubravka Markovic, Andrew P. Rasdal, Amy D.L. VandenBerg
  • Patent number: 10376143
    Abstract: Systems and methods of use involving sensors having a signal-to-noise ratio that is substantially unaffected by non-constant noise are provided for continuous analyte measurement in a host. In some embodiments, a continuous analyte measurement system is configured to be wholly, transcutaneously, intravascularly or extracorporeally implanted.
    Type: Grant
    Filed: December 31, 2013
    Date of Patent: August 13, 2019
    Assignee: DexCom, Inc.
    Inventors: Peter C. Simpson, Robert J. Boock, Mark C. Brister, Monica A. Rixman, Kum Ming Woo, Lisa Nguyen, Seth R. Brunner, Arthur Chee, Melissa A. Nicholas, Matthew D. Wightlin, Jack Pryor, Dubravka Markovic
  • Patent number: 10327936
    Abstract: An implant configured for ingestion by a patient. After the implant has been swallowed by the patient and is disposed within the target location, e.g. the patient's stomach, an inflation subcomponent causes the implant to expand from a compact delivery state to an expanded, volume-occupying, deployed state. In the deployed state the implant creates a sensation of satiety in the patient stomach and thereby aids in limiting food intake and obesity. After a predetermined time a deflation subcomponent is actuated and the implant reduces in size so as to allow it to pass through the remainder of the patient's digestive track. The device may further incorporate tracking and visualization subcomponents, as well as pharmaceutical delivery subcomponents.
    Type: Grant
    Filed: December 5, 2016
    Date of Patent: June 25, 2019
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Nelson Quintana, Kaushik A. Patel, Neil R. Drake, Antonio C. Llevares, Dubravka Markovic, Andrew P. Rasdal, Amy D. L. VandenBerg
  • Publication number: 20190000655
    Abstract: Intragastric volume-occupying devices and methods for treating obesity are provided. The devices, which are inflated by carbon dioxide, include an aluminum or silicon oxide barrier layer providing carbon dioxide retention and an alkylene vinyl alcohol polymer layer providing structural integrity in vivo.
    Type: Application
    Filed: August 24, 2018
    Publication date: January 3, 2019
    Inventors: Mark C. Brister, Kaushik A. Patel, Andrew P. Rasdal, Nelson Quintana, Neil R. Drake, Antonio C. Llevares, Dubravka Markovic, Amy D.L. VandenBerg
  • Patent number: 10085865
    Abstract: Intragastric volume-occupying devices and methods for treating obesity are provided. The devices, which are inflated by carbon dioxide, include an aluminum or silicon oxide barrier layer providing carbon dioxide retention and an alkylene vinyl alcohol polymer layer providing structural integrity in vivo.
    Type: Grant
    Filed: May 28, 2015
    Date of Patent: October 2, 2018
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Kaushik A. Patel, Andrew P. Rasdal, Nelson Quintana, Neil R. Drake, Antonio C. Llevares, Dubravka Markovic, Amy D. L. VandenBerg
  • Publication number: 20180185587
    Abstract: Systems and methods for integrating a continuous glucose sensor, including a receiver, a medicament delivery device, and optionally a single point glucose monitor are provided. Manual integrations provide for a physical association between the devices wherein a user (for example, patient or doctor) manually selects the amount, type, and/or time of delivery. Semi-automated integration of the devices includes integrations wherein an operable connection between the integrated components aids the user (for example, patient or doctor) in selecting, inputting, calculating, or validating the amount, type, or time of medicament delivery of glucose values, for example, by transmitting data to another component and thereby reducing the amount of user input required. Automated integration between the devices includes integrations wherein an operable connection between the integrated components provides for full control of the system without required user interaction.
    Type: Application
    Filed: February 27, 2018
    Publication date: July 5, 2018
    Inventors: James H. Brauker, Mark A. Tapsak, Sean T. Saint, Apurv Ullas Kamath, Paul V. Neale, Peter C. Simpson, Michael Robert Mensinger, Dubravka Markovic
  • Publication number: 20180185185
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Application
    Filed: February 27, 2018
    Publication date: July 5, 2018
    Inventors: Mark C. Brister, Paul D. Faucher, Neil R. Drake, Andrew P. Rasdal, Matthew S. Lake, Dubravka Markovic, Amy D.L. VandenBerg, Antonio C. Llevares, Josefina Nider
  • Patent number: 9937293
    Abstract: Systems and methods for integrating a continuous glucose sensor, including a receiver, a medicament delivery device, and optionally a single point glucose monitor are provided. Manual integrations provide for a physical association between the devices wherein a user (for example, patient or doctor) manually selects the amount, type, and/or time of delivery. Semi-automated integration of the devices includes integrations wherein an operable connection between the integrated components aids the user (for example, patient or doctor) in selecting, inputting, calculating, or validating the amount, type, or time of medicament delivery of glucose values, for example, by transmitting data to another component and thereby reducing the amount of user input required. Automated integration between the devices includes integrations wherein an operable connection between the integrated components provides for full control of the system without required user interaction.
    Type: Grant
    Filed: August 19, 2015
    Date of Patent: April 10, 2018
    Assignee: DexCom, Inc.
    Inventors: James H. Brauker, Mark A. Tapsak, Sean T. Saint, Apurv Ullas Kamath, Paul V. Neale, Peter C. Simpson, Michael Robert Mensinger, Dubravka Markovic
  • Publication number: 20180064569
    Abstract: Intragastric volume-occupying devices and methods for treating obesity are provided. The devices, which are inflated by carbon dioxide, include an aluminum or silicon oxide barrier layer providing carbon dioxide retention and an alkylene vinyl alcohol polymer layer providing structural integrity in vivo.
    Type: Application
    Filed: November 7, 2017
    Publication date: March 8, 2018
    Inventors: Mark C. Brister, Kaushik A. Patel, Andrew P. Rasdal, Nelson Quintana, Neil R. Drake, Antonio C. Llevares, Dubravka Markovic, Amy D.L. VandenBerg
  • Publication number: 20180008446
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Application
    Filed: August 29, 2017
    Publication date: January 11, 2018
    Inventors: Mark C. Brister, Paul D. Faucher, Neil R. Drake, Andrew P. Rasdal, Matthew S. Lake, Dubravka Markovic, Amy D.L. VandenBerg, Antonio C. Llevares, Josefina Nider
  • Patent number: 9827128
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Grant
    Filed: September 21, 2015
    Date of Patent: November 28, 2017
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Paul D. Faucher, Neil R. Drake, Andrew P. Rasdal, Matthew S. Lake, Dubravka Markovic, Amy D. L. VandenBerg, Antonio C. Llevares, Josefina Nider
  • Patent number: 9763609
    Abstract: Systems and methods of use involving sensors having a signal-to-noise ratio that is substantially unaffected by non-constant noise are provided for continuous analyte measurement in a host. In some embodiments, a continuous analyte measurement system is configured to be wholly, transcutaneously, intravascularly or extracorporeally implanted.
    Type: Grant
    Filed: January 2, 2013
    Date of Patent: September 19, 2017
    Assignee: Dexcom, Inc.
    Inventors: Peter C. Simpson, Robert J. Boock, James R. Petisce, Mark C. Brister, Monica A. Rixman, Kum Ming Woo, Lisa Nguyen, Seth R. Brunner, Arthur Chee, Melissa A. Nicholas, Matthew D. Wightlin, Jack Pryor, Dubravka Markovic
  • Patent number: 9662239
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Grant
    Filed: May 4, 2016
    Date of Patent: May 30, 2017
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Paul D. Faucher, Neil R. Drake, Andrew P. Rasdal, Matthew S. Lake, Dubravka Markovic, Amy D. L. VandenBerg, Antonio C. Llevares, Josefina Nider
  • Publication number: 20170079821
    Abstract: An implant configured for ingestion by a patient. After the implant has been swallowed by the patient and is disposed within the target location, e.g. the patient's stomach, an inflation subcomponent causes the implant to expand from a compact delivery state to an expanded, volume-occupying, deployed state. In the deployed state the implant creates a sensation of satiety in the patient stomach and thereby aids in limiting food intake and obesity. After a predetermined time a deflation subcomponent is actuated and the implant reduces in size so as to allow it to pass through the remainder of the patient's digestive track. The device may further incorporate tracking and visualization subcomponents, as well as pharmaceutical delivery subcomponents.
    Type: Application
    Filed: December 5, 2016
    Publication date: March 23, 2017
    Inventors: Mark C. Brister, Nelson Quintana, Kaushik A. Patel, Neil R. Drake, Antonio C. Llevares, Dubravka Markovic, Andrew P. Rasdal, Amy D.L. VandenBerg
  • Patent number: 9539132
    Abstract: An implant configured for ingestion by a patient. After the implant has been swallowed by the patient and is disposed within the target location, e.g. the patient's stomach, an inflation subcomponent causes the implant to expand from a compact delivery state to an expanded, volume-occupying, deployed state. In the deployed state the implant creates a sensation of satiety in the patient stomach and thereby aids in limiting food intake and obesity. After a predetermined time a deflation subcomponent is actuated and the implant reduces in size so as to allow it to pass through the remainder of the patient's digestive track. The device may further incorporate tracking and visualization subcomponents, as well as pharmaceutical delivery subcomponents.
    Type: Grant
    Filed: August 26, 2014
    Date of Patent: January 10, 2017
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Nelson Quintana, Kaushik A. Patel, Neil R. Drake, Antonio C. Llevares, Dubravka Markovic, Andrew P. Rasdal, Amy D.L. VandenBerg
  • Publication number: 20160256308
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Application
    Filed: May 4, 2016
    Publication date: September 8, 2016
    Inventors: Mark C. Brister, Paul D. Faucher, Neil R. Drake, Andrew P. Rasdal, Matthew S. Lake, Dubravka Markovic, Amy D.L. VandenBerg, Antonio C. Llevares, Josefina Nider
  • Publication number: 20160193064
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Application
    Filed: November 2, 2015
    Publication date: July 7, 2016
    Inventors: Mark C. Brister, Paul D. Faucher, Neil R. Drake, Andrew P. Rasdal, Matthew S. Lake, Dubravka Markovic, Amy D.L. VandenBerg, Antonio C. Llevares, Josefina Nider
  • Patent number: 9351862
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Grant
    Filed: March 27, 2014
    Date of Patent: May 31, 2016
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Paul D. Faucher, Neil R. Drake, Andrew P. Rasdal, Matthew S. Lake, Dubravka Markovic, Amy D. L. VandenBerg, Antonio C. Llevares, Josefina Nider
  • Publication number: 20160008154
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Application
    Filed: September 21, 2015
    Publication date: January 14, 2016
    Inventors: Mark C. Brister, Paul D. Faucher, Neil R. Drake, Andrew P. Rasdal, Matthew S. Lake, Dubravka Markovic, Amy D.L. VandenBerg, Antonio C. LIevares, Josefina Nider
  • Publication number: 20150374525
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and devices for inflating and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Application
    Filed: March 15, 2013
    Publication date: December 31, 2015
    Inventors: Mark C. Brister, Paul Faucher, Neil R. Drake, Andrew P. Rasdal, Matthew S. Lake, Dubravka Markovic, Amy D.L. VandenBerg, Antonio Llevares, Josefina Nider